This study aimed to evaluate the outcomes of BS in a cohort of 48 Uruguayan patients and investigate the interplay between BS and clinical and metabolic features, with a specific focus on FSTL1, an emerging biomarker associated with obesity and inflammation. The gene discussed is FSTL1; the disease is obesity due to melanocortin 4 receptor deficiency.